Trials / Conditions / BRAF V600E Mutation Positive

BRAF V600E Mutation Positive

5 registered clinical trials studyying BRAF V600E Mutation Positive — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer NCT05639413	UNICANCER	N/A
Recruiting	Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Re NCT05706779	Federation Francophone de Cancerologie Digestive	Phase 2
Recruiting	Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma NCT06653517	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Phase 2
Completed	Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers NCT04462471	Memorial Sloan Kettering Cancer Center	Phase 1
Completed	A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic NCT04317599	Pierre Fabre Medicament	—